20-31639045-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032609.3(COX4I2):c.28G>A(p.Val10Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000298 in 1,612,550 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_032609.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COX4I2 | NM_032609.3 | c.28G>A | p.Val10Met | missense_variant | 2/5 | ENST00000376075.4 | NP_115998.2 | |
COX4I2 | XM_005260581.4 | c.28G>A | p.Val10Met | missense_variant | 2/4 | XP_005260638.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COX4I2 | ENST00000376075.4 | c.28G>A | p.Val10Met | missense_variant | 2/5 | 1 | NM_032609.3 | ENSP00000365243 | P1 | |
COX4I2 | ENST00000490030.1 | n.58G>A | non_coding_transcript_exon_variant | 2/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152162Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000202 AC: 5AN: 247872Hom.: 0 AF XY: 0.00000746 AC XY: 1AN XY: 133964
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1460270Hom.: 1 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 726182
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152280Hom.: 0 Cov.: 31 AF XY: 0.0000537 AC XY: 4AN XY: 74458
ClinVar
Submissions by phenotype
Pancreatic insufficiency-anemia-hyperostosis syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 19, 2020 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 07, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with COX4I2-related conditions. This variant is present in population databases (rs199601484, gnomAD 0.01%). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 10 of the COX4I2 protein (p.Val10Met). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at